Government Briefs

The Best Defense Is A Strong Offense Allan Bromley, sworn in on August 4 as the president’s science adviser and the director of the Office of Science and Technology Policy, appears to differ from his predecessors on the relative importance of national security in strengthening the nation’s scientific base. While William Graham and George (“Jay” Keyworth, with similar backgrounds in black-box military research, stressed the importance of defense-related R&D, Bromley took

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Allan Bromley, sworn in on August 4 as the president’s science adviser and the director of the Office of Science and Technology Policy, appears to differ from his predecessors on the relative importance of national security in strengthening the nation’s scientific base. While William Graham and George (“Jay” Keyworth, with similar backgrounds in black-box military research, stressed the importance of defense-related R&D, Bromley took a decidedly more dovish approach at his recent Senate confirmation hearing. Asked by Sen. John Danforth (R-Mo.) about the 70-30 itnbalance between military and civilian research spending, Bromley replied that “at a time when tensions between the two superpowers seem to be easing, the Defense Department may need to put more into its basic research effort. I quite agree that the percentage spent on military expenditures seems extraordinarily high.” Likewise, the predominance of OSTP staffers with experience in the defense industry seems likely to wane. Bromley’s ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies